Nicholas C Kallan

This inventor holds 20 USPTO granted patents and 15 published patent applications, plus 9 CIPO patents and 14 EPO patents, primarily in AKT Protein Kinase Inhibitors. Top assignees: Array Biopharma Inc., Genentech, Inc., Covenentech, Inc.. Active years: 2011-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicholas C Kallan. Retrieved from https://idiyas.com/inventor/nicholas-c-kallan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20 (Patent Applications = 15)

% Patents Active = 70.0

CIPO Patents = 9

EPO Patents = 14 (Patent Applications = 10)

Average Co-Inventor Count = 11.9

ph-index = 8

Forward Citations = 165(Granted Patents)

Location History:

Louisville, CO (US) (2015)
Boulder, CO (US) (2011 - 2016)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2011-2016

Loading Chart...

Areas of Expertise:

AKT Protein Kinase

Pyrimidyl Cyclopentanes

Triazolopyridines

PIM Kinase Inhibitors

Substituted Piperazines

Dihydrofuro Pyrimidines

Hydroxylated Compounds

Methoxylated Compounds

5H-Cyclopenta[D]Pyrimidines

Imidazo[1,2-a]Pyridine

20 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9409886 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2016-08-09),

2. 9359340 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors (2016-06-07),

3. 9328091 - 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors (2016-05-03),

4. 9303040 - Substituted piperazines as AKT inhibitors (2016-04-05),

5. 8987251 - Triazolopyridine compounds as PIM kinase inhibitors (2015-03-24),

6. 8895566 - 5H-cyclopenta[d]pyrimidines as AKT protein kinase inhibitors (2014-11-25),

7. 8853216 - Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor (2014-10-07),

8. 8853199 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2014-10-07),

9. 8846683 - Pyrimidyl cyclopentanes as Akt protein kinase inhibitors (2014-09-30),

10. 8846681 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2014-09-30),

11. 8835434 - Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors (2014-09-16),

12. 8680114 - AKT protein kinase inhibitors (2014-03-25),

13. 8618097 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2013-12-31),

14. 8575145 - Triazolopyridine compounds as PIM kinase inhibitors (2013-11-05),

15. 8377937 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2013-02-19),

Title: The Inventive Journey of Nicholas C Kallan

Introduction: Nicholas C Kallan is a renowned inventor based in Boulder, Colorado, known for his groundbreaking contributions to various industries.

Latest Patents: Nicholas C Kallan holds several patents in the fields of renewable energy, sustainable technology, and advanced materials, showcasing his innovative spirit and commitment to creating a better future.

Career Highlights: With a background in engineering and a passion for problem-solving, Nicholas C Kallan has led numerous successful projects that have revolutionized the way we approach environmental challenges and technological advancements.

Collaborations: Throughout his career, Nicholas C Kallan has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and collaboration in the industry.

Conclusion: Nicholas C Kallan's dedication to innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, shaping the landscape of technology and sustainability for years to come.

Profile summary based on public USPTO records.